FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-103457.
(The FASEB Journal. 2008;22:3525-3536.)
© 2008 FASEB
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.07-103457v1
22/10/3525    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sveinbjörnsson, B.
Right arrow Articles by Kogner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sveinbjörnsson, B.
Right arrow Articles by Kogner, P.

Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy

Baldur Sveinbjörnsson*,§,1,2, Agnes Rasmuson*,1, Ninib Baryawno*, Min Wan{dagger}, Ingvild Pettersen§, Frida Ponthan*,||, Abiel Orrego{ddagger}, Jesper Z. Haeggström{dagger}, John I. Johnsen* and Per Kogner*

* Childhood Cancer Research Unit, Department of Woman and Child Health,

{dagger} Department of Medical Biochemistry and Biophysics, and

{ddagger} Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden;

§ Department of Cell Biology and Histology, Faculty of Medicine, University of Tromsö, Tromsö, Norway; and

|| Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

2Correspondence: Childhood Cancer Research Unit, Astrid Lindgren Children’s Hospital, Q6:05, Karolinska Hospital, S-171 76 Stockholm, Sweden, E-mail: baldur.sveinbjornsson{at}ki.se

The metabolism of arachidonic acid by the cyclooxygenase (COX) or lipoxygenase (LO) pathways generates eicosanoids that have been implicated in the pathogenesis of a variety of human diseases, including cancer. In this study, we examined the expression and significance of components within the 5-LO pathway in human neuroblastoma, an embryonal tumor of the sympathetic nervous system. High expression of 5-LO, 5-LO-activating protein (FLAP), leukotriene A4 hydrolase, leukotriene C4 synthase, and leukotriene receptors was detected in a majority of primary neuroblastoma tumors and all cell lines investigated. Expression of 5-LO and FLAP was evident in tumor cells but not in nonmalignant adrenal medulla where neuroblastomas typically arise. Moreover, neuroblastoma cells produce leukotrienes, and stimulation of neuroblastoma cells with leukotrienes increased neuroblastoma cell viability. Inhibitors of 5-LO (AA-861), FLAP (MK-886), or the leukotriene receptor antagonist montelukast inhibited neuroblastoma cell growth by induction of G1-cell cycle arrest and apoptosis. Similarly, specific 5-LO and leukotriene receptor silencing by small interfering RNA decreased neuroblastoma cell growth. These findings provide new insights into the pathobiology of neuroblastoma, and the use of leukotriene pathway inhibitors as a novel adjuvant therapy for children with neuroblastoma warrants further consideration.—Sveinbjörnsson, B., Rasmuson, A., Baryawno, N., Wan, M., Ingvild Pettersen, I., Frida Ponthan, F., Orrego, A., Haeggström, J. Z., Johnsen, J. I., Kogner, P. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.


Key Words: eicosanoids • 5-lipoxygenase • apoptosis




This article has been cited by other articles:


Home page
J. Immunol.Home page
G.-Y. Kim, J.-W. Lee, H.-C. Ryu, J.-D. Wei, C.-M. Seong, and J.-H. Kim
Proinflammatory Cytokine IL-1{beta} Stimulates IL-8 Synthesis in Mast Cells via a Leukotriene B4 Receptor 2-Linked Pathway, Contributing to Angiogenesis
J. Immunol., April 1, 2010; 184(7): 3946 - 3954.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Gleissman, R. Yang, K. Martinod, M. Lindskog, C. N. Serhan, J. I. Johnsen, and P. Kogner
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates
FASEB J, March 1, 2010; 24(3): 906 - 915.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.